|
|
Pemphigus Vulgaris
|
|
Pemphigus Vulgaris
JCI table of contents December, 2005 Nov 10, 2005
...autoimmune blistering disease models, which have distinct disease pathology - bullous pemphigoid (BP), pemphigus foliaceus (PF), and pemphigus vulgaris (PV). ...
- EurekAlert (press release),
Aspreva Pharmaceuticals reports third quarter 2005 results Nov 2, 2005
...lupus nephritis. Our phase III studies in myasthenia gravis and pemphigus vulgaris are also progressing according to plan.". Mr. Glickman ...
- Yahoo! News (press release)
Aspreva Pharmaceuticals reports third quarter 2005 results Nov 2, 2005
Our phase III studies in myasthenia gravis and pemphigus vulgaris are also progressing according to plan." Mr. Glickman added, "We expanded our clinical ...
- PR Newswire (press release),
Blisters, as body rejects the skin Oct 24, 2005
...supervised the treatment. He was diagnosed with Pemphigus Vulgaris (PV), confirmed by biopsy and immuno-florescent study. PV is ...
- Calcutta Telegraph,
Aspreva Pharmaceuticals earns $3.2M US Q3 profit compared with ... Nov 2, 2005
The company has three Phase 3 clinical programs underway with CellCept, including lupus nephritis, myasthenia gravis and pemphigus vulgaris.
- Canada.com,
MASS Opportunities: A Biotechnology Investment Conference ... Nov 2, 2005
...in safer and more effective products with reduced development and marketing risks for obesity, multiple sclerosis, rheumatoid arthritis and pemphigus vulgaris. ...
- Genetic Engineering News,
Peptimmune Closes $20.4 Million Series C Private FinancingJul 15, 2005
Peptimmune's other clinical development program is PI-0824 peptide immunotherapy for the treatment of pemphigus vulgaris, a rare autoimmune skin disease. ...
- Yahoo News
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Pemphigus Vulgaris
you may want to try searching the Internet using the Google search box below.
|
|
|
